Effect of BMI on lifetime risk for diabetes in the U.S - PubMed (original) (raw)
doi: 10.2337/dc06-2544. Epub 2007 Mar 19.
Affiliations
- PMID: 17372155
- DOI: 10.2337/dc06-2544
Effect of BMI on lifetime risk for diabetes in the U.S
K M V Narayan et al. Diabetes Care. 2007 Jun.
Abstract
Objective: At birth, the lifetime risk of developing diabetes is one in three, but lifetime risks across BMI categories are unknown. We estimated BMI-specific lifetime diabetes risk in the U.S. for age-, sex-, and ethnicity-specific subgroups.
Research design and methods: National Health Interview Survey data (n = 780,694, 1997-2004) were used to estimate age-, race-, sex-, and BMI-specific prevalence and incidence of diabetes in 2004. U.S. Census Bureau age-, race-, and sex-specific population and mortality rate estimates for 2004 were combined with two previous studies of mortality to estimate diabetes- and BMI-specific mortality rates. These estimates were used in a Markov model to project lifetime risk of diagnosed diabetes by baseline age, race, sex, and BMI.
Results: Lifetime diabetes risk at 18 years of age increased from 7.6 to 70.3% between underweight and very obese men and from 12.2 to 74.4% for women. The lifetime risk difference was lower at older ages. At 65 years of age, compared with normal-weight male subjects, lifetime risk differences (percent) increased from 3.7 to 23.9 percentage points between overweight and very obese men and from 8.7 to 26.7 percentage points for women. The impact of BMI on diabetes duration also decreased with age.
Conclusions: Overweight and especially obesity, particularly at younger ages, substantially increases lifetime risk of diagnosed diabetes, while their impact on diabetes risk, life expectancy, and diabetes duration diminishes with age.
Similar articles
- Forecasting the obesity epidemic in the aging U.S. population.
Wang YC, Colditz GA, Kuntz KM. Wang YC, et al. Obesity (Silver Spring). 2007 Nov;15(11):2855-65. doi: 10.1038/oby.2007.339. Obesity (Silver Spring). 2007. PMID: 18070778 - Depression and anxiety among US adults: associations with body mass index.
Zhao G, Ford ES, Dhingra S, Li C, Strine TW, Mokdad AH. Zhao G, et al. Int J Obes (Lond). 2009 Feb;33(2):257-66. doi: 10.1038/ijo.2008.268. Epub 2009 Jan 6. Int J Obes (Lond). 2009. PMID: 19125163 - The effect of obesity on overall, circulatory disease- and diabetes-specific mortality.
Rogers RG, Hummer RA, Krueger PM. Rogers RG, et al. J Biosoc Sci. 2003 Jan;35(1):107-29. J Biosoc Sci. 2003. PMID: 12537160 - Lifetime risk for diabetes mellitus in the United States.
Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Narayan KM, et al. JAMA. 2003 Oct 8;290(14):1884-90. doi: 10.1001/jama.290.14.1884. JAMA. 2003. PMID: 14532317 - Impact of gender on diabetes mellitus and its associated cardiovascular risk factors.
Singh R, Wiegers SE, Goldstein BJ. Singh R, et al. J Gend Specif Med. 2001;4(3):28-36. J Gend Specif Med. 2001. PMID: 11605353 Review.
Cited by
- Platelet/High-Density Lipoprotein Ratio (PHR) Predicts Type 2 Diabetes in Obese Patients: A Retrospective Study.
Alshuweishi Y, Abudawood A, Alfayez D, Almufarrih AA, Alanazi F, Alshuweishi FA, Almuqrin AM. Alshuweishi Y, et al. Healthcare (Basel). 2024 Aug 3;12(15):1540. doi: 10.3390/healthcare12151540. Healthcare (Basel). 2024. PMID: 39120243 Free PMC article. - Patients with diabetes and obesity exhibit characteristics in eating and coping behaviors and personality traits.
Saito M, Usui I, Sugawara N, Jojima T, Sakurai S, Kishi H, Sagara M, Tomaru T, Iijima T, Shimoda K, Yasui-Furukori N, Aso Y. Saito M, et al. Diabetol Int. 2024 Apr 16;15(3):528-534. doi: 10.1007/s13340-024-00721-w. eCollection 2024 Jul. Diabetol Int. 2024. PMID: 39101177 - Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus.
Yland JJ, Huybrechts KF, Wesselink AK, Straub L, Chiu YH, Seely EW, Patorno E, Bateman BT, Mogun H, Wise LA, Hernández-Díaz S. Yland JJ, et al. Diabetes Care. 2024 Sep 1;47(9):1688-1695. doi: 10.2337/dc23-2056. Diabetes Care. 2024. PMID: 39042587 - Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.
Krause C, Britsemmer JH, Bernecker M, Molenaar A, Taege N, Lopez-Alcantara N, Geißler C, Kaehler M, Iben K, Judycka A, Wagner J, Wolter S, Mann O, Pfluger P, Cascorbi I, Lehnert H, Stemmer K, Schriever SC, Kirchner H. Krause C, et al. Elife. 2024 Jul 22;12:RP92075. doi: 10.7554/eLife.92075. Elife. 2024. PMID: 39037913 Free PMC article. - The addition of mycoprotein to a mixed-meal impacts postprandial glucose kinetics without altering blood glucose concentrations: a randomised controlled trial.
Whelehan G, West S, Abdelrahman DR, Murton AJ, Finnigan TJA, Wall BT, Stephens FB. Whelehan G, et al. Eur J Clin Nutr. 2024 Sep;78(9):757-764. doi: 10.1038/s41430-024-01470-4. Epub 2024 Jul 13. Eur J Clin Nutr. 2024. PMID: 39003347 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical